Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer

The AGO Kommission Ovar already published a statement in 2013, warning about the uncritical use of hyperthermic intraperitoneal chemotherapy (HIPEC) outside controlled studies. This statement has now been updated after the most recent literature was reviewed by AGO Kommission Ovar, the AGO Study Gro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Geburtshilfe Frauenheilkd
Egile Nagusiak: Harter, P., du Bois, A., Mahner, S., Pfisterer, J., Ortmann, O., Marth, C., Fink, D., Hilpert, F., Wagner, U., Sehouli, J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Georg Thieme Verlag KG 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4771502/
https://ncbi.nlm.nih.gov/pubmed/26941446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0035-1568169
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak